Stereotaxis Inc (STXS) USD0.001

Sell:$2.47Buy:$2.50$0.11 (4.64%)

Prices delayed by at least 15 minutes
Sell:$2.47
Buy:$2.50
Change:$0.11 (4.64%)
Prices delayed by at least 15 minutes
Sell:$2.47
Buy:$2.50
Change:$0.11 (4.64%)
Prices delayed by at least 15 minutes

Company Information

About this company

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Key people

David Leo Fischel
Chairman of the Board, Chief Executive Officer
Kimberly R. Peery
Chief Financial Officer
David W. Benfer
Lead Independent Director
Nathan Fischel
Director
Nachum Shamir
Director
Myriam J. Curet
Independent Director
Ross B. Levin
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US85916J4094
  • Market cap
    $200.81m
  • Employees
    122
  • Shares in issue
    84.73m
  • Exchange
    Nyse American LLC
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.